{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:12:34Z","timestamp":1790161954841,"version":"4.1.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>\n                    <jats:bold>Aims\/Introduction:<\/jats:bold>\n                    Diabetic kidney disease (DKD) is defined as diabetes with impaired renal function, elevated urinary albumin excretion, or both. DKD is one of the most common microvascular complications of diabetes and plays an important role in the cause of end-stage renal disease (ESRD). About 5% of people with type 2 diabetes (T2DM) already have kidney damage at the time they are diagnosed, but other triggers of renal insufficiency, such as obesity, hyperlipidemia, glomerular atherosclerosis are often present, making it difficult to define \u201cdiabetic kidney disease\u201d or \u201cdiabetic nephropathy\u201d precisely in epidemiology or clinical practice. Therefore, the aim of this study is to identify diabetic patients with CKD at an early stage, and evaluate the value of tubular injury markers including \u03b11-microglobulin (\u03b11-MG), \u03b22-microglobulin (\u03b22-MG), N-acetyl-beta-D-glucosaminidase (NAG) and Urinary retinol binding protein (URBP) in the development of diabetes to DKD.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Materials and methods:<\/jats:bold>\n                    We recruited a total of 182 hospitalized patients with T2DM in the First Affiliated Hospital of Zhengzhou University from February 2018 to April 2023. We collected basic clinical characteristics and laboratory biochemical parameters of the patients. Based on their levels of urinary albumin creatinine ratio (UACR) and glomerular filtration rate (GFR), patients were divided into DM group (UACR\u226430\u00a0mg\/g and eGFR\u226590\u00a0mL\/min\/1.73\u00a0m\n                    <jats:sup>2<\/jats:sup>\n                    ,\n                    <jats:italic>n<\/jats:italic>\n                    = 63) and DKD group (UACR&amp;gt;30\u00a0mg\/g or eGFR&amp;lt;90\u00a0mL\/min\/1.73\u00a0m\n                    <jats:sup>2<\/jats:sup>\n                    ,\n                    <jats:italic>n<\/jats:italic>\n                    = 119) excluding other causes of chronic kidney disease. We further developed diagnostic models to improve the ability to predict the risk of developing DKD by screening potential risk factors using univariate and multivariate logistic regression analysis. Calibration plots and curve analysis were used to validate the model and clinical usefulness. Next, we screened patients with relatively normal estimated glomerular filtration rate (eGFR) (\u226590\u00a0mL\/min\/1.73\u00a0m\n                    <jats:sup>2<\/jats:sup>\n                    ) to investigate whether tubular injury markers could accurately predict the risk of DKD in patients with normal renal function. We defined the rate of GFR decline as a prognostic indicator of renal function in patients and collected the information of the re-hospitalized DKD patients to determine whether the relevant indicators had an impact on the renal prognosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    The patients with DKD had higher levels of tubular injury markers than patients with DM. URBP, \u03b11-MG, eGFR were statistically different in both univariate and multivariate logistic regression analyses and displayed great predictive power after modeling with an area under curve of 0.987. The calibration curve showed medium agreement. Decision curve showed it would add more net benefits for clinical decision. After adjusting eGFR and serum creatinine (Scr), URBP was demonstrated to be associated with early renal function impairment.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Tubular injury markers play an important role in early diabetic renal function impairment.\n                  <\/jats:p>","DOI":"10.3389\/fphys.2023.1173982","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T03:58:32Z","timestamp":1697687912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Diagnostic value of \u03b11-MG and URBP in early diabetic renal impairment"],"prefix":"10.3389","volume":"14","author":[{"given":"Yukun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanzheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000505155","article-title":"Neutrophil gelatinase-associated lipocalin and retinol-binding protein-4 as biomarkers for diabetic kidney disease","volume":"45","author":"Abbasi","year":"","journal-title":"Kidney Blood Press Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000505155","article-title":"Neutrophil gelatinase-associated lipocalin and retinol-binding protein-4 as biomarkers for diabetic kidney disease","volume":"45","author":"Abbasi","year":"","journal-title":"Kidney Blood Press Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among US adults with diabetes","volume":"316","author":"Afkarian","year":"2016","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s11684-017-0542-7","article-title":"Normoalbuminuric diabetic kidney disease","volume":"11","author":"Chen","year":"2017","journal-title":"Front. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0200945","DOI":"10.1371\/journal.pone.0200945","article-title":"Urine proteome analysis by C18 plate-matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy","volume":"13","author":"Chen","year":"2018","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s00125-018-4741-9","article-title":"SUMMIT Investigators. Serum kidney injury molecule 1 and \u03b22-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes","volume":"62","author":"Colombo","year":"2019","journal-title":"Diabetologia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s11892-009-0075-9","article-title":"The growing economic burden of diabetic kidney disease","volume":"9","author":"Foley","year":"2009","journal-title":"Curr. Diab Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.ajkd.2015.01.013","article-title":"Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes","volume":"66","author":"Foster","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12020-011-9509-7","article-title":"Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study","volume":"41","author":"Fu","year":"2012","journal-title":"Endocrine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1046\/j.1523-1755.1999.00721.x","article-title":"The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?","volume":"56","author":"Gilbert","year":"1999","journal-title":"Kidney Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2337\/diacare.26.2.338","article-title":"Urinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore","volume":"26","author":"Hong","year":"2003","journal-title":"Diabetes Care"},{"key":"B13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s1056-8727(00)00119-7","article-title":"Urinary protein excretion in Type 2 diabetes with complications","volume":"14","author":"Hong","year":"","journal-title":"J. Diabetes its Complicat."},{"key":"B14","first-page":"220","article-title":"Urine protein excretion among Chinese patients with type 2 diabetes mellitus","volume":"55","author":"Hong","year":"","journal-title":"Med. J. Malays."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","article-title":"Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer","volume":"34","author":"Huang","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jdiacomp.2017.08.009","article-title":"Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy","volume":"31","author":"Hwang","year":"2017","journal-title":"J. Diabetes Complicat."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e22191","DOI":"10.1002\/jcla.22191","article-title":"Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients","volume":"32","author":"Jiang","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"B18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1681\/ASN.2006030221","article-title":"Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure","volume":"18","author":"Liangos","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ejim.2008.12.012","article-title":"The role of tubular injury in diabetic nephropathy","volume":"20","author":"Magri","year":"2009","journal-title":"Eur. J. Intern Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2215\/CJN.04980515","article-title":"Prognostic value of tubulointerstitial lesions, urinary N-Acetyl-\u03b2-d-Glucosaminidase, and urinary \u03b22-microglobulin in patients with type 2 diabetes and biopsy-proven diabetic nephropathy","volume":"11","author":"Mise","year":"","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2215\/CJN.04980515","article-title":"Prognostic value of tubulointerstitial lesions, urinary N-acetyl-\u03b2-D-glucosaminidase, and urinary \u03b22-microglobulin in patients with type 2 diabetes and biopsy-proven diabetic nephropathy","volume":"11","author":"Mise","year":"","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cca.2013.02.019","article-title":"Diabetic nephropathy: traditional to proteomic markers","volume":"421","author":"Moresco","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"B24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1053\/j.ajkd.2010.12.022","article-title":"Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients","volume":"57","author":"Nauta","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.2337\/dc10-0345","article-title":"Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy","volume":"33","author":"Papale","year":"2010","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1097\/HJH.0b013e3283495cd6","article-title":"Clinical significance of nonalbuminuric renal impairment in type 2 diabetes","volume":"29","author":"Penno","year":"2011","journal-title":"J. Hypertens."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2042018819891110","DOI":"10.1177\/2042018819891110","article-title":"Evaluation of urinary biomarkers for prediction of diabetic kidney disease: a propensity score matching analysis","volume":"10","author":"Qin","year":"2019","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/bjh.17706","article-title":"Urinary retinol binding protein predicts renal outcome in systemic immunoglobulin light-chain (AL) amyloidosis","volume":"194","author":"Rezk","year":"2021","journal-title":"Br. J. Haematol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s13205-019-1593-z","article-title":"Urinary N-acetyl-beta-d-glucosaminidase (NAG) with neutrophil gelatinase-associated lipocalin (NGAL) improves the diagnostic value for proximal tubule damage in diabetic kidney disease","volume":"9","author":"Siddiqui","year":"2019","journal-title":"3 Biotech."},{"key":"B30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.ackd.2005.01.008","article-title":"Tubular changes in early diabetic nephropathy","volume":"12","author":"Thomas","year":"2005","journal-title":"Adv. Chronic Kidney Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jdiacomp.2012.06.006","article-title":"Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy","volume":"26","author":"Titan","year":"2012","journal-title":"J. Diabetes its Complicat."},{"key":"B32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/leu.2016.195","article-title":"Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients","volume":"31","author":"Vignon","year":"2017","journal-title":"Leukemia"},{"key":"B33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/jcp.36.3.253","article-title":"Alpha-1-microglobulin: an indicator protein for renal tubular function","volume":"36","author":"Yu","year":"1983","journal-title":"J. Clin. Pathol."},{"key":"B34","first-page":"15","article-title":"Detection of early stage renal disease by elevation of certain low molecular Weight proteins in urine of diabetes patients","volume":"1","author":"Zahra","year":"2014","journal-title":"Int. J. Biol. Sci. Appl."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e7079","DOI":"10.7717\/peerj.7079","article-title":"The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes","volume":"7","author":"Zhang","year":"2019","journal-title":"PeerJ"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2023.1173982\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T03:58:37Z","timestamp":1697687917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2023.1173982\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":35,"alternative-id":["10.3389\/fphys.2023.1173982"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2023.1173982","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"article-number":"1173982"}}